BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7620238)

  • 21. Effect of Th2 type cytokines on hCLCA1 and mucus expression in cystic fibrosis airways.
    Hauber HP; Lavigne F; Hung HL; Levitt RC; Hamid Q
    J Cyst Fibros; 2010 Jul; 9(4):277-9. PubMed ID: 20542744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
    Mall M; Grubb BR; Harkema JR; O'Neal WK; Boucher RC
    Nat Med; 2004 May; 10(5):487-93. PubMed ID: 15077107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer.
    Olsen JC; Johnson LG; Stutts MJ; Sarkadi B; Yankaskas JR; Swanstrom R; Boucher RC
    Hum Gene Ther; 1992 Jun; 3(3):253-66. PubMed ID: 1379473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collection of normal canine tracheobronchial secretions.
    Adams GK; Aharonson EF; Reasor MJ; Proctor DF
    J Appl Physiol; 1976 Feb; 40(2):. PubMed ID: 1248990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of airway liquid secretion and its effect on the physical properties of airway mucus.
    Trout L; King M; Feng W; Inglis SK; Ballard ST
    Am J Physiol; 1998 Feb; 274(2):L258-63. PubMed ID: 9486211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium.
    Martin C; Coolen N; Wu Y; Thévenot G; Touqui L; Prulière-Escabasse V; Papon JF; Coste A; Escudier E; Dusser DJ; Fajac I; Burgel PR
    Eur Respir J; 2013 Dec; 42(6):1553-62. PubMed ID: 23520314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reevaluation of the action of reducing agents on soluble mucus glycoproteins from human bronchial secretion.
    Le Treut A; Lamblin G; Houdret N; Degand P; Roussel P
    Biochimie; 1981; 63(5):425-34. PubMed ID: 7236742
    [No Abstract]   [Full Text] [Related]  

  • 28. A model for tracheobronchial clearance of inhaled particles in man and a comparison with data.
    Lee PS; Gerrity TR; Hass FJ; Lourenco RV
    IEEE Trans Biomed Eng; 1979 Nov; 26(11):624-30. PubMed ID: 511197
    [No Abstract]   [Full Text] [Related]  

  • 29. The anatomy, physiology, pharmacology and pathology of tracheobronchial mucus secretion and the use of expectorant drugs in human disease.
    Richardson PS; Phipps RJ
    Pharmacol Ther B; 1978; 3(4):441-79. PubMed ID: 32559
    [No Abstract]   [Full Text] [Related]  

  • 30. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibroses.
    Köhler D; App E; Schmitz-Schumann M; Würtemberger G; Matthys H
    Eur J Respir Dis Suppl; 1986; 146():319-26. PubMed ID: 3465558
    [No Abstract]   [Full Text] [Related]  

  • 32. Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways.
    Abdullah LH; Evans JR; Wang TT; Ford AA; Makhov AM; Nguyen K; Coakley RD; Griffith JD; Davis CW; Ballard ST; Kesimer M
    JCI Insight; 2017 Mar; 2(6):e89752. PubMed ID: 28352653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucociliary clearance in obstructive lung diseases. Correlations to the immotile cilia syndrome.
    Mossberg B; Afzelius B; Camner P
    Eur J Respir Dis Suppl; 1986; 146():295-301. PubMed ID: 3465555
    [No Abstract]   [Full Text] [Related]  

  • 34. [Histochemistry of the mucus in mucoviscidosis].
    Dudorkinová D; Lojda Z
    Cesk Patol; 1972 Aug; 8(3):147-53. PubMed ID: 4263452
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of neutrophil protenase enzymes on the release of mucus from feline and human airway cultures.
    Lundgren JD; Rieves RD; Mullol J; Logun C; Shelhamer JH
    Respir Med; 1994 Aug; 88(7):511-8. PubMed ID: 7972975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucus transportability: the bovine trachea and frog palate models compared.
    Wills PJ; Pritchard K; Cole PJ
    Eur Respir J; 1998 Oct; 12(4):837-41. PubMed ID: 9817155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung defense mechanisms (first of two parts).
    Newhouse M; Sanchis J; Bienenstock J
    N Engl J Med; 1976 Oct; 295(18):990-8. PubMed ID: 787790
    [No Abstract]   [Full Text] [Related]  

  • 38. Airway surface pH in subjects with cystic fibrosis.
    McShane D; Davies JC; Davies MG; Bush A; Geddes DM; Alton EW
    Eur Respir J; 2003 Jan; 21(1):37-42. PubMed ID: 12570106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation-dependent regulation of apical membrane chloride channels in normal and cystic fibrosis airway epithelium.
    Welsh MJ; Li M; McCann JD; Clancy JP; Anderson MP
    Ann N Y Acad Sci; 1989; 574():44-51. PubMed ID: 2561330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction.
    Hauber HP; Tsicopoulos A; Wallaert B; Griffin S; McElvaney NG; Daigneault P; Mueller Z; Olivenstein R; Holroyd KJ; Levitt RC; Hamid Q
    Eur Respir J; 2004 Jun; 23(6):846-50. PubMed ID: 15218996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.